Perspective Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of CATX for the last quarter is 369.00 k USD, and it's 29.85% lower compared to the previous quarter. The net income of Q3 24 is -15.12 M USD.